Research News and Research

RSS

Research scientists develop bioengineered treatment for targeting pancreatic cancer

Research scientists from Massachusetts General Hospital, Boston, have developed a novel bioengineered treatment that has shown promise in targeting pancreatic cancer without causing damage to healthy noncancer cells, a typical problem of chemotherapy.

14 Oct 2009

University of North Carolina awarded grant to continue research on rare disease-causing gene mutations

The University of North Carolina at Chapel Hill has been awarded a five-year, $6.2 million renewal grant to continue its work as part of the National Institutes of Health's Rare Diseases Clinical Research Network (RDCRN).

14 Oct 2009

OSUCCC-James and Global Vision Technologies collaborate to deliver a web-based patient registry solution

The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) has entered into a contract with Global Vision Technologies (GVT) to create and deliver a new, web-based Photo Dynamic Therapy patient registry solution -- ClinicalPURSUIT -- to help streamline the data collection and outcomes analysis process.

14 Oct 2009

MUC1 protein defends against the stomach ulcer bacterium, according to study

A special protein in the lining of the stomach has been shown to be an important part of the body's defense against the stomach ulcer bacterium Helicobacter pylori in a new study from the Sahlgrenska Academy at the University of Gothenburg. The discovery may explain why the bacterium makes some people more ill than others.

14 Oct 2009

Integrated Diagnostics launched to develop diagnostic tools and innovative biomarkers

Integrated Diagnostics launched officially today with more than $30 million in funding. A pre-eminent team of scientists and investors are behind the company, which was founded by renowned biotechnology innovator Dr. Leroy Hood. Integrated Diagnostics will focus on developing personalized and preventive diagnostics based on breakthroughs using genomic and proteomic technologies to identify organ-specific proteins.

14 Oct 2009

NY Senators co-sponsors bill to establish comprehensive program for lung cancer

Today, Lung Cancer Alliance (LCA) hailed the support of Senators Chuck Schumer (D-NY) and Kirsten Gillibrand (D-NY) who have signed on as co-sponsors of a bill to establish the first ever multi-agency, comprehensive program targeted at lung cancer.

14 Oct 2009

The Regence Foundation unveils signature philanthropic program to access quality palliative care

The Regence Foundation unveiled its signature philanthropic program today, Sojourns, to foster best practices, leadership and collaboration that help people with life-threatening and incurable illness to access quality palliative care in their own community. The Foundation also announced its first Sojourns grant to OHSU Doernbecher Children's Hospital for its Bridges pediatric palliative care program.

14 Oct 2009

Diabetes care undergoes a paradigm shift to delay onset of full-blown disease

Diabetes care is undergoing a paradigm shift in which insulin is being prescribed earlier, for more conditions, in order to delay the onset of full-blown disease, according to a study released today by Scientia Advisors.

14 Oct 2009

Springer and CAS announce publication of science and technology reports

Springer and the Chinese Academy of Sciences (CAS) announce the publication of strategic reports planning the next 40 years of progress in science and technology (S&T).

14 Oct 2009

HTDS to release its next 90 to 180 day forward guidance report

HTDS www.htdsmedical.com - The Company intends to release its next 90 to 180 day forward guidance concurrent with its profile launch on www.stockprofile.com .

14 Oct 2009

Researchers develop magneto-nano sensor chip to detect cancer

Searching for biomarkers that can warn of diseases such as cancer while they are still in their earliest stage is likely to become far easier thanks to an innovative biosensor chip developed by Stanford University researchers.

14 Oct 2009

Blocking newly discovered second molecular pathway may prevent angiogenesis: UCLA researchers

Researchers at the University of California Los Angeles (UCLA) have found that a second molecular pathway may need to be blocked to prevent malignant cells from creating new blood vessels [angiogenesis]. A study of patients with pancreatic cancer showed that CXCL5 may be a key molecule in the angiogenesis switch—the point at which cells stop being normal and start producing blood vessels that feed malignancy.

14 Oct 2009

Antisense Therapeutics completes repeat-dosing toxicology studies for ATL1103

Antisense Therapeutics Limited is pleased to announce that the Company has now completed repeat-dosing toxicology studies for ATL1103 in two species -- mouse and non-human primate. Draft study reports from the study contractors in the United States have been received, and the toxicology outcomes from these studies support ANP's plans for the continued development of ATL1103.

14 Oct 2009

Study: Animals are not essential for human cancer research

A recently released paper published in the journal Alternatives to Laboratory Animals (ATLA 37, 399-416), presents a serious challenge to long-standing claims that animals are an important part of human cancer research.

14 Oct 2009

Brain researcher finds how the epilepsy and pain drug works

A Duke University Medical Center researcher who spent years looking for the signals that prompt the brain to form new connections between neurons has found one that may explain precisely how a well-known drug for epilepsy and pain actually works.

14 Oct 2009

Household brands join to support the lifesaving work of St. Jude Children's Research Hospital

For the tenth year, some of the public's favorite household brands have joined forces to support the lifesaving work of St. Jude Children's Research Hospital(R), one of the world's premier pediatric cancer research centers.

14 Oct 2009

AAPS to present eLearning Webinar on Nanotechnology in Drug Design and Development

The American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific society of approximately 12,000 members employed in industry, academia, government and other research institutes worldwide.

14 Oct 2009

2009 American Cancer Society Pathfinder in Palliative Care awarded to James A. Block

James A. Block, M.D., president of J.A. Block Health Associates, will receive the inaugural 2009 American Cancer Society Pathfinder in Palliative Care Award, which recognizes individuals who have demonstrated innovation and ingenuity in their contributions to the advancement of the field of palliative care.

14 Oct 2009

NIBIB awards $1M grant to develop a rapid test for sepsis-related pathogens

Smiths Detection today announces the award of a $1m, two-year grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) to develop a rapid test for eight micro-organisms that commonly cause burn/wound infections leading to septicemia (blood-poisoning).

14 Oct 2009

Researchers identify genetic mechanisms involved in the formation and survival of L-form bacteria

Researchers at the Johns Hopkins Bloomberg School of Public Health have for the first time identified the genetic mechanisms involved in the formation and survival of L-form bacteria. Their findings are described in a study published October 6 in the journal PLoS ONE.

14 Oct 2009

Research News and Research

Research scientists develop bioengineered treatment for targeting pancreatic cancer

University of North Carolina awarded grant to continue research on rare disease-causing gene mutations

OSUCCC-James and Global Vision Technologies collaborate to deliver a web-based patient registry solution

MUC1 protein defends against the stomach ulcer bacterium, according to study

Integrated Diagnostics launched to develop diagnostic tools and innovative biomarkers

NY Senators co-sponsors bill to establish comprehensive program for lung cancer

The Regence Foundation unveils signature philanthropic program to access quality palliative care

Diabetes care undergoes a paradigm shift to delay onset of full-blown disease

Springer and CAS announce publication of science and technology reports

HTDS to release its next 90 to 180 day forward guidance report

Researchers develop magneto-nano sensor chip to detect cancer

Blocking newly discovered second molecular pathway may prevent angiogenesis: UCLA researchers

Antisense Therapeutics completes repeat-dosing toxicology studies for ATL1103

Study: Animals are not essential for human cancer research

Brain researcher finds how the epilepsy and pain drug works

Household brands join to support the lifesaving work of St. Jude Children's Research Hospital

AAPS to present eLearning Webinar on Nanotechnology in Drug Design and Development

2009 American Cancer Society Pathfinder in Palliative Care awarded to James A. Block

NIBIB awards $1M grant to develop a rapid test for sepsis-related pathogens

Researchers identify genetic mechanisms involved in the formation and survival of L-form bacteria

A guide to advancing biotherapeutic research eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms